Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Corcept Therapeutics Inc shares valued at $159,060 were sold by Swisher Daniel N JR on Aug 11 ’25. At $72.30 per share, Swisher Daniel N JR sold 2,200 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Guyer William sold 35,007 shares, netting a total of over 2,512,452 in proceeds. Following the sale of shares at $71.77 each, the insider now holds 5,487 shares.
Before that, Swisher Daniel N JR had added 2,200 shares to its account. In a trade valued at $159,060, the Director bought Corcept Therapeutics Inc shares for $72.30 each.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
On last trading session, Corcept Therapeutics Inc [NASDAQ: CORT] plunged -1.10% to $72.0. The stock’s lowest price that day was $71.2055, but it reached a high of $72.96 in the same session. During the last five days, there has been a surge of approximately 0.73%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 111.08%. Shares of the company reached a 52-week high of $117.33 on 03/31/25 and a 52-week low of $49.00 on 01/13/25.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 71.15, which, if violated, would cause prices to drop to 70.30. In the upper region, resistance lies at 72.90. The next price resistance is at 73.81. RSI (Relative Strength Index) is 52.99 on the 14-day chart, showing neutral technical sentiment.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp steep in short interest on 2025-07-31 dropping by -0.4 million shares to 11.05 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 11.45 million shares. A decline of -3.64% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.13 of the overall float, the days-to-cover ratio (short ratio) decline to 12.13.
Which companies own the most shares of Corcept Therapeutics Inc (CORT)?
In terms of Corcept Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 140 in the next 12 months, up nearly 92.31% from the previous closing price of $72.8. Analysts anticipate Corcept Therapeutics Inc stock to reach 145 by 2025, with the lowest price target being 135. In spite of this, 4 analysts ranked Corcept Therapeutics Inc stock as Buy at the end of 2025. On August 01, 2022, Truist assigned a price target of “a Hold” to the stock and downgraded coverage with a $30.
